Literature DB >> 6715796

Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.

G Verde, P Loli, M E Berselli, M Tagliaferri, D Dallabonzana, G Oppizzi, A Liuzzi, P G Chiodini, G Luccarelli, S Lodrini.   

Abstract

The case of a young boy bearing a pituitary PRL secreting adenoma (20-30,000 ng/ml) with the unusual association of clinical and endocrinological features of Cushing's disease successfully treated with bromocriptine is described. Brain computed tomography evidenced a huge pituitary adenoma leading to visual field defects and raised intracranial pressure. Due to the very large size of the tumor, which rendered the complete neurosurgical removal unlikely, medical treatment with bromocriptine (10 mg/day) was started. Follow-up for more than six months demonstrated an impressive reduction of tumor size, the lowering of prolactin levels into the normal range, the normalization of visual field, and the regression of both clinical and biochemical signs of hypercortisolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715796     DOI: 10.1007/BF03348376

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Persistent lactation associated with pituitary tumor and hyperadrenal corticism; successfully treated with pituitary radiation.

Authors:  M E LEVIN; W H DAUGHADAY; I LEVY
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

2.  A rapid method for the determination of total urinary 17-ketosteroids.

Authors:  I J DREKTER; S PEARSON
Journal:  J Clin Endocrinol Metab       Date:  1947-12       Impact factor: 5.958

3.  A quantitative color reaction for cortisone and related 17,21-dihydroxy-20-ketosteroids.

Authors:  C C PORTER; R H SILBER
Journal:  J Biol Chem       Date:  1950-07       Impact factor: 5.157

4.  Cure of Cushing's disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica.

Authors:  S T Bigos; F Robert; G Pelletier; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

5.  Abnormal lactation with Cushing's syndrome--a case report.

Authors:  V B Mahesh; S D Pria; R B Greenblatt
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

6.  Long term bromocriptine therapy in Cushing's disease.

Authors:  L P Kapcala; I M Jackson
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

7.  Concurrent production of adrenocorticotropin and prolactin from two distinct cell lines in a single pituitary adenoma: a detailed immunohistochemical analysis.

Authors:  S H Sherry; A T Guay; A K Lee; E T Hedley Whyte; M Federman; S R Freidberg; P D Woolf
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

8.  Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.

Authors:  P Chiodini; A Liuzzi; R Cozzi; G Verde; G Oppizzi; D Dallabonzana; B Spelta; F Silvestrini; G Borghi; G Luccarelli; E Rainer; R Horowski
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

9.  Cushing's disease: management by transsphenoidal pituitary microsurgery.

Authors:  S T Bigos; M Somma; E Rasio; R C Eastman; A Lanthier; H H Johnston; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

10.  Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.

Authors:  A Kuwayama; N Kageyama; T Nakane; M Watanabe; N Kanie
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.